Cargando…
189P Assessment of seroconversion after SARS-CoV2 vaccination in patients with lung cancer
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976190/ http://dx.doi.org/10.1016/j.annonc.2022.02.114 |
| _version_ | 1784680510939725824 |
|---|---|
| author | Trontzas, I.P. Vathiotis, I. Gomatou, G. Grammoustianou, M. Tsamis, I. Anagnostakis, M. Sakka, V. Poulakou, G. Syrigos, K.N. Kotteas, E.A. |
| author_facet | Trontzas, I.P. Vathiotis, I. Gomatou, G. Grammoustianou, M. Tsamis, I. Anagnostakis, M. Sakka, V. Poulakou, G. Syrigos, K.N. Kotteas, E.A. |
| author_sort | Trontzas, I.P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8976190 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89761902022-04-04 189P Assessment of seroconversion after SARS-CoV2 vaccination in patients with lung cancer Trontzas, I.P. Vathiotis, I. Gomatou, G. Grammoustianou, M. Tsamis, I. Anagnostakis, M. Sakka, V. Poulakou, G. Syrigos, K.N. Kotteas, E.A. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2022-04 2022-04-02 /pmc/articles/PMC8976190/ http://dx.doi.org/10.1016/j.annonc.2022.02.114 Text en Copyright © 2022 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Trontzas, I.P. Vathiotis, I. Gomatou, G. Grammoustianou, M. Tsamis, I. Anagnostakis, M. Sakka, V. Poulakou, G. Syrigos, K.N. Kotteas, E.A. 189P Assessment of seroconversion after SARS-CoV2 vaccination in patients with lung cancer |
| title | 189P Assessment of seroconversion after SARS-CoV2 vaccination in patients with lung cancer |
| title_full | 189P Assessment of seroconversion after SARS-CoV2 vaccination in patients with lung cancer |
| title_fullStr | 189P Assessment of seroconversion after SARS-CoV2 vaccination in patients with lung cancer |
| title_full_unstemmed | 189P Assessment of seroconversion after SARS-CoV2 vaccination in patients with lung cancer |
| title_short | 189P Assessment of seroconversion after SARS-CoV2 vaccination in patients with lung cancer |
| title_sort | 189p assessment of seroconversion after sars-cov2 vaccination in patients with lung cancer |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976190/ http://dx.doi.org/10.1016/j.annonc.2022.02.114 |
| work_keys_str_mv | AT trontzasip 189passessmentofseroconversionaftersarscov2vaccinationinpatientswithlungcancer AT vathiotisi 189passessmentofseroconversionaftersarscov2vaccinationinpatientswithlungcancer AT gomatoug 189passessmentofseroconversionaftersarscov2vaccinationinpatientswithlungcancer AT grammoustianoum 189passessmentofseroconversionaftersarscov2vaccinationinpatientswithlungcancer AT tsamisi 189passessmentofseroconversionaftersarscov2vaccinationinpatientswithlungcancer AT anagnostakism 189passessmentofseroconversionaftersarscov2vaccinationinpatientswithlungcancer AT sakkav 189passessmentofseroconversionaftersarscov2vaccinationinpatientswithlungcancer AT poulakoug 189passessmentofseroconversionaftersarscov2vaccinationinpatientswithlungcancer AT syrigoskn 189passessmentofseroconversionaftersarscov2vaccinationinpatientswithlungcancer AT kotteasea 189passessmentofseroconversionaftersarscov2vaccinationinpatientswithlungcancer |